ITI Pharma & Healthcare Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :
| 1 Year | 3 Year | 5 Year | 9 Year | |
| CAGR(%) | 15.26 | 18.95 | N/A | N/A |
| Average Rolling Returns(%) | 18.84 | 19.49 | N/A | N/A |
The Current NAV of ITI Pharma & Healthcare Fund - Growth - Direct Plan is ₹20.10.
It is better to invest in a fund with a longer track record as ITI Pharma & Healthcare Fund - Growth - Direct Plan cannot be assessed for consistency of out-performance. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.
ITI Pharma & Healthcare Fund - Growth - Direct Plan fund’s expense ratio is 0.58%
The process for redemption is
The AUM of ITI Pharma & Healthcare Fund - Growth - Direct Plan is currently ₹276 Crores.
The Top three stocks are Sun Pharma. Inds., Divis Laboratories and Apollo Hospital Ent. and account for 28% of its portfolio. Top 5 and 10 stocks of fund account for 37% and 57% of fund’s portfolio respectively.
Top three sectors of ITI Pharma & Healthcare Fund - Growth - Direct Plan fund are Healthcare, Miscellaneous and Chemicals accounting for 98% of the total portfolio.
Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.
The category of ITI Pharma & Healthcare Fund - Growth - Direct Plan Fund is Equity - Sectoral Fund - Pharma & Health Care.
Animesh Singh and Nilay Dalal manage the ITI Pharma & Healthcare Fund - Growth - Direct Plan Fund.
ITI Pharma & Healthcare Fund - Growth - Direct Plan current PE ratio is 62.30 and PB ratio is 9.22
The asset allocation of ITI Pharma & Healthcare Fund - Growth - Direct Plan is Stocks : 99.27%, Debt : 0.71% and Gold : 0%
The minimum SIP amount for ITI Pharma & Healthcare Fund - Growth - Direct Plan is ₹500.00 and minimum lumpsum is ₹5000.00
The exit load for ITI Pharma & Healthcare Fund - Growth - Direct Plan is 0.50% on or before 3 months, NIL after 3 months
|
Name of the IA registered
with SEBI: |
The Alchemists Ark Pvt. Ltd. |
|
Logo:
|
|
|
Trade/Brand
Name of IA: |
MoneyWorks4Me Investment Advisers |
|
Brand Logo:
|
 |
|
SEBI Registration Number:
|
INA000013323 Validity – May 16, 2019 – Perpetual |
|
Registration:
|
Non-Individual |
|
BSE Enlistment No:
|
1187 |
|
Address:
|
B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045 |
|
Compliance Officer
Details: |
Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com |
Telephone: +919860359463 Address: Same as IA |
|
Grievance Officer
Details: |
Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com |
Telephone: +919860919463 Address: Same as IA |
|
Principal Officer
Details: |
Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com |
Telephone: +919175899463 Address: Same as IA |
|
Standard Warning:
|
Investment in securities market are subject to market risks. Read all the related documents carefully before investing. |
|
|
Disclaimer:
|
Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. |
|
